Innophos Holdings (IPHS) Earns Daily Media Sentiment Rating of 0.19
Media stories about Innophos Holdings (NASDAQ:IPHS) have been trending somewhat positive this week, Accern Sentiment reports. Accern scores the sentiment of press coverage by analyzing more than twenty million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores nearest to one being the most favorable. Innophos Holdings earned a media sentiment score of 0.19 on Accern’s scale. Accern also assigned news headlines about the specialty chemicals company an impact score of 47.5948801468979 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the media stories that may have effected Accern Sentiment Analysis’s scoring:
- Innophos Acquires NutraGenesis To Complement Its Branded Food, Health And Nutrition Portfolio (finance.yahoo.com)
- KeyCorp Analysts Reduce Earnings Estimates for Innophos Holdings, Inc. (IPHS) (americanbankingnews.com)
- Brokerages Anticipate Innophos Holdings, Inc. (IPHS) to Announce $0.56 EPS (americanbankingnews.com)
- Analyzing Innophos Holdings (IPHS) & Its Competitors (americanbankingnews.com)
A number of brokerages have recently commented on IPHS. Zacks Investment Research downgraded Innophos Holdings from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 4th. KeyCorp reissued a “hold” rating on shares of Innophos Holdings in a research report on Wednesday, November 1st.
Shares of Innophos Holdings (NASDAQ:IPHS) traded down $0.79 during trading on Friday, hitting $43.53. The stock had a trading volume of 184,900 shares, compared to its average volume of 113,224. Innophos Holdings has a 1-year low of $41.66 and a 1-year high of $58.22. The firm has a market capitalization of $834.94, a P/E ratio of 18.02 and a beta of 0.88. The company has a debt-to-equity ratio of 0.83, a quick ratio of 1.49 and a current ratio of 2.86.
Innophos Holdings (NASDAQ:IPHS) last announced its quarterly earnings data on Tuesday, October 31st. The specialty chemicals company reported $0.78 EPS for the quarter, topping the Zacks’ consensus estimate of $0.72 by $0.06. Innophos Holdings had a return on equity of 13.90% and a net margin of 6.19%. The business had revenue of $184.00 million during the quarter, compared to the consensus estimate of $179.33 million. During the same period in the previous year, the company posted $0.69 earnings per share. The business’s revenue for the quarter was down 1.1% on a year-over-year basis. analysts forecast that Innophos Holdings will post 2.5 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 6th. Stockholders of record on Friday, November 17th will be given a dividend of $0.48 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 4.41%. The ex-dividend date of this dividend is Thursday, November 16th. Innophos Holdings’s dividend payout ratio is presently 88.07%.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
Receive News & Stock Ratings for Innophos Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innophos Holdings Inc. and related stocks with our FREE daily email newsletter.